📰 Abt News
Page 119 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
August 10, 2023
Tempus Wealth Planning LLC trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 38.9% during the first quarter, HoldingsChannel.com reports. The fund owned 2,511 shares of the healthcare product maker’s stock after selling 1,601 shares during the quarter. Tempus Wealth Planning LLC’s holdings in Abbott Laboratories were worth $254,000 at the end of […]
August 10, 2023
Brooktree Capital Management cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 49.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,661 shares of the healthcare product maker’s stock after selling 2,585 shares during the […]
August 10, 2023
Personal CFO Solutions LLC cut its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,229 shares of the healthcare product maker’s stock after selling 1,113 shares during the […]
August 10, 2023
Personal CFO Solutions LLC cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,229 shares of the healthcare product maker’s stock after selling 1,113 shares during […]
August 9, 2023
Equitable Trust Co. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 36.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 27,964 shares of the healthcare product maker’s stock after selling 15,991 shares during the quarter. Equitable Trust Co.’s holdings […]
August 9, 2023
Parthenon LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 33,329 shares of the healthcare product maker’s stock after selling 526 shares during the period. Parthenon LLC’s holdings in […]
August 9, 2023
Culbertson A N & Co. Inc. lowered its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 0.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 96,081 shares of the healthcare product maker’s stock after selling 397 shares during the period. Abbott […]
August 9, 2023
Americana Partners LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,592 shares of the healthcare product maker’s stock after purchasing an additional 360 shares during the period. Americana […]
August 9, 2023
Culbertson A N & Co. Inc. reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,081 shares of the healthcare product maker’s stock after selling 397 shares during the period. Abbott Laboratories […]
August 9, 2023
Arcblock (ABT) traded down 1.7% against the US dollar during the 24-hour period ending at 11:00 AM E.T. on August 9th. Arcblock has a market cap of $8.31 million and approximately $110,010.48 worth of Arcblock was traded on exchanges in the last 24 hours. During the last seven days, Arcblock has traded 7% higher against […]